The synergistic effect of the combination of liraglutide and dapagliflozin on glycaemic control and cardiometabolic risk factors in type 2 diabetes patients

被引：0
|
作者：
Pappas, S.
Koutsovasilis, A.
Apostolou, O.
Gougourelas, D.
Bletsa, E.
Pappa, M.
Ntionias, D.
Kordinas, V.
Sotiropoulos, A.
机构：
[1] Gen Hosp Nikaia Piraeus, Dept Internal Med 3, Athens, Greece
[2] Gen Hosp Nikaia Piraeus, Ctr Diabet, Athens, Greece
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
715
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [1] Assessment of the Long-Term Effect of the Liraglutide and Dapagliflozin Combination on Glycemic Control and Cardiometabolic Risk Factors in Type 2 Diabetes Mellitus Patients
    Sotiropoulos, Alexios
    Koutsovasilis, Anastasios G.
    Pappa, Maria
    Ntionias, Dimitrios
    Papadaki, Despina
    Kapsalakis, Georgios
    Tsiaglis, Stavros
    Apostolou, Ourania
    Peppas, Theodoros
    [J]. DIABETES, 2017, 66 : A304 - A304
  • [2] The effect of dulaglutide in glycaemic control cardiovascular risk factors and qualitative factors in type 2 diabetes patients under treatment with liraglutide
    Sotiropoulos, A.
    Koutsovasilis, A.
    Antoniou, A.
    Kordinas, V.
    Pappa, M.
    Gerogianni, M.
    Bousboulas, S.
    Peppas, T.
    [J]. DIABETOLOGIA, 2019, 62 : S372 - S372
  • [3] The effect of ideglira on glycaemic control and cardiometabolic risk factors compared to the non fixed administration of degludec and liraglutide
    Sotiropoulos, A.
    Koutsovasilis, A.
    Pappa, M.
    Antoniou, A.
    Ntionias, D.
    Tamvakos, C.
    Bousboulas, S.
    Peppas, T.
    [J]. DIABETOLOGIA, 2017, 60 : S367 - S367
  • [4] Retinopathy risk factors in patients with type 2 diabetes on liraglutide
    Mahzari, Moeber M.
    Alanazy, Abdulmalik M.
    Feroz, Zeeshan
    Almani, Khalid M.
    Alghamdi, Meshari A.
    Almadani, Abdulaziz S.
    Alzahrani, Majed K.
    Alibrahim, Ahmed R.
    Badri, Motasim
    [J]. MEDICINE, 2024, 103 (29)
  • [5] Dapagliflozin improves glycaemic control in insulin-resistant patients with type 2 diabetes
    Wilding, J. P. H.
    Norwood, P.
    T'joen, C.
    Bastien, A.
    List, J. F.
    Fiedorek, F. T.
    [J]. DIABETOLOGIA, 2009, 52 : S76 - S76
  • [6] Postprandial glycaemic control in patients with Type 2 diabetes on a combination of insulin degludec and liraglutide vs each component individually
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L. H.
    Bode, B. W.
    [J]. DIABETIC MEDICINE, 2014, 31 : 51 - 51
  • [7] Factors associated to glycaemic control in patients with type 2 diabetes
    Panarotto, Daniel
    Teles, Alisson Roberto
    Schumacher, Marina Verdi
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 314 - 321
  • [8] An audit of glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus
    P. Downey
    L. O’Shea
    D. Dillon
    M. Corbett
    S. Sreenan
    [J]. Irish Journal of Medical Science, 2002, 171 (Suppl 5) : 11 - 12
  • [9] The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
    Stuart J. McGurnaghan
    Liam Brierley
    Thomas M. Caparrotta
    Paul M. McKeigue
    Luke A. K. Blackbourn
    Sarah H. Wild
    Graham P. Leese
    Rory J. McCrimmon
    John A. McKnight
    Ewan R. Pearson
    John R. Petrie
    Naveed Sattar
    Helen M. Colhoun
    [J]. Diabetologia, 2019, 62 : 621 - 632
  • [10] The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
    McGurnaghan, Stuart J.
    Brierley, Liam
    Caparrotta, Thomas M.
    McKeigue, Paul M.
    Blackbourn, Luke A. K.
    Wild, Sarah H.
    Leese, Graham P.
    McCrimmon, Rory J.
    McKnight, John A.
    Pearson, Ewan R.
    Petrie, John R.
    Sattar, Naveed
    Colhoun, Helen M.
    [J]. DIABETOLOGIA, 2019, 62 (04) : 621 - 632
12345